Atlantic Healthcare selected as finalist for Clinical & Research Excellence Awards 2018


Recognition of alicaforsen in Rare Disease Drug Development category highlights commitment to addressing unmet need in inflammatory bowel diseaseCambridge, UK, February 28, 2018. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging…

Read More

Atlantic Healthcare is attending the JP Morgan Healthcare Conference (January 8-11, San Francisco) and the Crohn’s and Colitis Congress (January 11-18, Las Vegas)


Cambridge, UK; January 8, 2018. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, today announced that CEO, Toby Wilson Waterworth, and Clinical…

Read More

Atlantic Healthcare to present at the Stifel 2017 Healthcare Conference in New York on November 15, 2017


Cambridge, UK; November 8, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, today announced that CEO Toby Wilson Waterworth will present at…

Read More

Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn’s disease and Ulcerative Colitis


Existing efficacy and safety data support progress of alicaforsen targeted-release tablets into Phase 1 developmentCambridge, UK; May 30, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a…

Read More

Atlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indication


Eminent U.S. pharma veteran William Ringo and founding investor Andrew Boyce appointed non-executive directors; Interim Chairman Thomas Wellner takes on role permanently; Lorin Johnson steps down from BoardCambridge, UK; May 22, 2017. Atlantic…

Read More

Atlantic Healthcare initiates FDA rolling submission of its New Drug Application for alicaforsen in the treatment of pouchitis


Filing of the nonclinical package marks a key milestone in the process towards obtaining marketing approval of alicaforsen for the treatment of pouchitisCambridge, UK; May 1, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging…

Read More